Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Arch. Dis. Child. Fetal Neonatal Ed.. Published Online First: 19 February 2008. doi:10.1136/adc.2007.133140
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EL-Khuffash, A. F.
Right arrow Articles by Molloy, E. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EL-Khuffash, A. F.
Right arrow Articles by Molloy, E. J

Original articles

Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death of severe intraventricular haemorrhage

Afif Faisal EL-Khuffash 1*, Declan Barry 1, Kevin Walsh 2, Peter Graham Davis 3 and Eleanor J Molloy 4

1 National Maternity Hospital, Republic of Ireland
2 Our Ladys Hospital for Sick Children, Republic of Ireland
3 Royal Women's Hospital, Melbourne, Australia
4 National Maternity hospital, Republic of Ireland

* To whom correspondence should be addressed. E-mail: afif_faisal{at}hotmail.com.

Accepted 5 February 2008


*   Abstract

Background: A patent ductus arteriosus (PDA) in preterm infants is associated with increased risk of intraventricular haemorrhage (IVH), and death. Cardiac troponin T (cTnT) and Pro-B-type Natriuretic Peptide (NTpBNP) are markers of cardiac function and can predict poor outcome in adults.

Aims: To determine whether echocardiography and cTnT/NTpBNP levels at 48 hours predict death before discharge or severe IVH in preterm infants with a PDA.

Methods: Infants born < 32 weeks gestation or < 1500g underwent echocardiographic and cTnT/NTpBNP measurements at 12 and 48 hours of life. Infants were divided according to their status at discharge: a closed PDA at 48 hours, infants with a PDA at 48 hours and IVH III/IV and/or death, and infants with a PDA at 48 hours without IVH III/IV or death.

Results: Eighty infants with a median gestation of 28 weeks [IQR:26.1–29.5] and birth weight 1.06 kg [0.8 –1.21] were included. At 48 hours, infants with a PDA and IVH III/IV and/or death had significantly higher median NTpBNP/cTnT levels compared to infants with a PDA without IVH III/IV and/or death and those with spontaneous PDA closure (NTpBNP: 9282, 5121, and 740 pmol/L respectively, p=0.008, and cTnT: 0.66, 0.25, and 0.13 µg/L respectively, p=0.027). There were no differences in echocardiographic parameters of PDA size, LA:Ao ratio, left and right ventricular outputs between the PDA groups.

Conclusions: NTpBNP and cTnT in conjunction with echocardiography may provide a basis for trials of targeted medical treatment in infants with a PDA.


Keywords: NTpBNP, cTnT, patent ductus arteriosus, preterm infant







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health